Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions
Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]
*Sign up for news summaries and alerts from 340B Report